Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2007

Jan 19, 2007

30339_dirs_2007-01-19_4b8b14eb-e2df-4df2-b867-35b60d4baf77.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-01-10

Reporting Person: Paproski John E (Vice President - Innovations)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 14312.759 Direct
Common Stock 5661.1837 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $14.4100 2012-03-08 Common Stock (9000.0000) Direct
Stock Option (Right to Buy) $25.5300 2015-03-09 Common Stock (7000.0000) Direct
Stock Option (Right to Buy) $19.3650 2015-05-05 Common Stock (8200.0000) Direct
Stock Option (Right to Buy) $32.5850 2016-02-24 Common Stock (4641.0000) Direct

Footnotes

F1: The option is exercisable in four equal installments beginning on the first anniversary of the grant.